The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing

In a 2016 executive report, ORC International explored the challenges facing today's biopharma organizations when planning for their clinical and commercial drug supply needs. These challenges stem from short shelf lives, long product lead times that require companies to plan up to two years in advance and an industry-wide lack of capacity. These challenges are only further exacerbated by the inevitability of demand forecast inaccuracies.

Download this special accompanying report "The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing" by Bioprocess Technology Consultants to discover how choosing partners who can offer greater flexibility to respond to inevitable changes in demand is among the best strategies to mitigate risk.

The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing

In a 2016 executive report, ORC International explored the challenges facing today’s biopharma organizations when planning for their clinical and commercial drug supply needs. These challenges stem from short shelf lives, long product lead times that require companies to plan up to two years in advance and an industry-wide lack of capacity. These challenges are only further exacerbated by the inevitability of demand forecast inaccuracies.

Download this special accompanying report “The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing” by Bioprocess Technology Consultants to discover how choosing partners who can offer greater flexibility to respond to inevitable changes in demand is among the best strategies to mitigate risk.